169
Participants
Start Date
December 10, 2018
Primary Completion Date
November 13, 2020
Study Completion Date
November 13, 2020
Etripamil NS 70 mg
All patients will receive a total of 200 micro-liters of etripamil NS 70 mg via the Aptar Pharma Nasal Spray Bidose System each time they self-administer study drug.
Aptar Pharma Nasal Spray Bidose System
Patients will self-administer the study drug using the Aptar Pharma Nasal Spray Bidose System. The devices will be prefilled and packaged into child-resistant boxes.Instructions for its use will be provided in the study drug box.
Weill Cornell Medical Center, New York
Trinity Medical WNY, PC, Buffalo
MedStar Health Research Institute, Baltimore
The Presbyterian Hospital DBA Novant Health Heart and Vascular Institute, Charlotte
Piedmont Heart Institute, Atlanta
Columbus Regional Research Institute, Columbus
Edgewater Medical Research, New Smyrna Beach
Baptist Health Ambulatory Services, Jacksonville
Mayo Clinic - Jacksonville, Jacksonville
Heart House Research Foundation, LLC, Springfield
Iowa Heart Center, West Des Moines
Mayo Clinic, Rochester
Black Hills Cardiovascular Research, Rapid City
Arkansas Cardiology, Little Rock
Baylor College of Medicine, Houston
Baylor Scott and White Research Institute - Round Rock, Round Rock
South Denver Cardiology Associates, P.C, Littleton
Arizona Arrhythmia Research Center, Phoenix
Los Alamitos Cardiovascular, Los Alamitos
Georgia Arrythmia Consultants&Research Institute, Macon
Atlantic Health System - Morristown Medical Center, Morristown
IHC Health Services Inc. DBA Intermountain Medical Center, Murray
Libin Cardiovascular Institute of Alberta - University of Calgary, Calgary
Royal Alexandra Hospital, Edmonton
Vancouver General Hospital - Research Institute ; Gordon and Leslie Diamond Health Centre, Vancouver
Victoria Cardiac Arrhythmia Trials, Inc., Victoria
University of Manitoba, St Boniface General Hospital, Winnipeg
Cambridge Cardiac Care Centre, Cambridge
Dawson Road Medical Centre, Guelph
Hamilton Health Sciences, Hamilton
Partners in Advanced Cardiac Evaluation (PACE) Cardiology Clinic, Newmarket
St. Michael's Hospital, Toronto
Montreal Heart Institute - Institut de Cardiologie de Montréal, Montreal
CIUSSS de l'Estrie - CHUS ; Hôpital Fleurimont, Sherbrooke
Lead Sponsor
Collaborators (1)
Medpace, Inc.
INDUSTRY
Milestone Pharmaceuticals Inc.
OTHER